Deals this week: HitGen, Calithera Biosciences, Esperion Therapeutics

HitGen has signed an agreement with LEO Pharma to use its advanced technology platform to discover new small molecules.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news
More News: Pharmaceuticals